Universal Health Services - UHS Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last year. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" UHS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UHS, but not buy additional shares or sell existing shares.
View UHS analyst ratings or view top-rated stocks.

14 brokerages have issued 1-year price targets for Universal Health Services' stock. Their UHS share price forecasts range from $90.00 to $167.00. On average, they expect the company's share price to reach $131.29 in the next year. This suggests a possible upside of 3.3% from the stock's current price.
View analysts price targets for UHS or view top-rated stocks among Wall Street analysts.

Universal Health Services' stock was trading at $140.89 on January 1st, 2023. Since then, UHS shares have decreased by 9.8% and is now trading at $127.10.
View the best growth stocks for 2023 here.

Universal Health Services saw a increase in short interest in February. As of February 28th, there was short interest totaling 1,750,000 shares, an increase of 18.2% from the February 13th total of 1,480,000 shares. Based on an average daily trading volume, of 684,200 shares, the days-to-cover ratio is currently 2.6 days. Currently, 2.9% of the shares of the stock are short sold.
View Universal Health Services' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 24th 2023.
View our UHS earnings forecast.

Universal Health Services, Inc. (NYSE:UHS) issued its quarterly earnings data on Monday, February, 27th. The health services provider reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.96 by $0.06. The health services provider earned $3.45 billion during the quarter, compared to analyst estimates of $3.40 billion. Universal Health Services had a net margin of 5.04% and a trailing twelve-month return on equity of 12.31%. The firm's revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period last year, the company earned $2.95 earnings per share.
Read the conference call transcript.

Universal Health Services announced a quarterly dividend on Wednesday, January 18th. Shareholders of record on Wednesday, March 1st will be given a dividend of $0.20 per share on Wednesday, March 15th. This represents a $0.80 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date is Tuesday, February 28th.
Read our dividend analysis for UHS.

ETFs with the largest weight of Universal Health Services (NYSE:UHS) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Pure Value ETF (RPV), Cambria Shareholder Yield ETF (SYLD), LeaderShares AlphaFactor US Core Equity ETF (LSAF) and First Trust Mid Cap US Equity Select ETF (RNMC).

Universal Health Services (NYSE:UHS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.64%. The dividend payout ratio is 8.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UHS will have a dividend payout ratio of 7.07% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for UHS.

Universal Health Services announced that its Board of Directors has authorized a stock repurchase plan on Thursday, February 24th 2022, which allows the company to buyback $1,400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 12.1% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Universal Health Services updated its FY23 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of $9.50-$10.50 for the period, compared to the consensus estimate of $10.83. The company issued revenue guidance of $14.044-$14.314 billion, compared to the consensus revenue estimate of $13.98 billion.

237 employees have rated Universal Health Services Chief Executive Officer Alan B. Miller on Glassdoor.com. Alan B. Miller has an approval rating of 63% among the company's employees. This puts Alan B. Miller in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Universal Health Services investors own include UnitedHealth Group (UNH), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC), Walt Disney (DIS), Intel (INTC), Johnson & Johnson (JNJ), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Universal Health Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "UHS."

Shares of UHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of UHS stock can currently be purchased for approximately $127.10.

Universal Health Services (NYSE:UHS) has a market capitalization of $8.98 billion and generates $13.40 billion in revenue each year. The health services provider earns $675.61 million in net income (profit) each year or $9.15 on an earnings per share basis.

The company employs 93,800 workers across the globe.

Universal Health Services' mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The official website for the company is www.uhsinc.com. The health services provider can be reached via phone at (610) 768-3300, via email at karen.sterner@uhsinc.com, or via fax at 610-768-3336.